NCT00741442View on ClinicalTrials.gov

A Study of RDEA806 in Hyperuricemic Subjects With Symptomatic Gout

PHASE2CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

April 30, 2009

Study Completion Date

September 30, 2009

Conditions
Hyperuricemia
Interventions
DRUG

RDEA806

Uricosuric agent for the treatment of gout

DRUG

Placebo

Matching Placebo.

Trial Locations (1)

M9W 4L6

Toronto

Sponsors
All Listed Sponsors
lead

Ardea Biosciences, Inc.

INDUSTRY